BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS
SAN DIEGO, Dec. 21, 2021 /PRNewswire/ -- BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic antibody therapeutics, today... | December 21, 2021
Source: marketscreener.com